Chanson International (CHSN) announced that its self-developed “Songkang Meal” series of nasogastric nutrition formulas has received official registration approval as a Food for Special Medical Purpose in China. The product has been adopted for use in several hospitals in Xinjiang. As the Company’s first FSMP product, “Songkang Meal” represents Chanson’s expansion into the medical nutrition and FSMP market, presenting an opportunity for new revenue streams.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHSN:
- Chanson reports on diversity initiatives, responsible business practices
- Chanson International announces new formulation for sugar
- Chanson International Reports 2024 Financial Growth Amidst Challenges
- 3 Penny Stocks to Watch Now, 4/8/25
- Chanson International Holding Restructures Share Capital to Boost Market Position